Colorectal GI Cancer
Featuring: Dr. Hagen Kennecke
Non-Colorectal GI Cancer
Featuring: Dr. Sharlene Gill
Featuring: Dr. Christine Brezden-Masley
Featuring: Dr. Mark Doherty
Colorectal and Non Colorectal GI Cancer
Featuring: Dr. Benoit Samson
IDEA Study (High Risk Stage 2 Patients)
Featuring: Dr. Scott Berry Dr. Sharlene Gill Dr. Marc Peeters
Foxtrot Trial
ABC-06
Phase 3 Trial of 1st Line Chemo vs Pembrolizumab vs Chemo + Pembrolizumab for Metastatic Gastric CA
Phase 3 Trial of 2nd Line Pembrolizumab vs Placebo for HCC
Polo Trial
Apact Trial
Trials of Oxaliplatin-based Therapy 3 vs. 6 months in Colorectal Cancer
Featuring: Dr. Tim Iveson
Namodenoson in Patients with Child-Pugh B HCC
Featuring: Dr. Salomon Stemmer
NRG-GI002 Study
Featuring: Dr. Thomas George
Foxtrot Study
Featuring: Dr. Dion Morton
Esophago-Gastro Cancer
Keynote Lecture: Newer Advances in the Treatment of Late Stage MCRC
Featuring: Dr. Michael Morse
Pancreatic Cancer
Featuring: Dr. Yoo-Joung Ko
Case-Based Presentations In GI Cancers
Featuring: Dr. Suneil Khanna
Hepatobiliary Cancer
Colorectal Cancer
Featuring: Dr. Ron Burkes
GI Colorectal
Featuring: Dr. Patricia Tang
GI Non-Colorectal
Best of Oncology East 2018 - Non-Colorectal GI Cancer
Best of Oncology East 2018 - Colorectal GI Cancer
Featuring: Dr. Scott Berry
Pain Management & Holistic Care
Featuring: Dr. Martin Chasen Dr. Scott Berry
Steatorrhea, Pancreatic Enzyme Insufficiency, & Diagnosing Diabetes
Featuring: Dr. Michael Sawyer Jessica Kasnik
Comorbidities and Concomitant Use of Medications
Featuring: Dr. Tim Asmis Lisa Rambout
Diabetic Patient Considerations and Neuropathy Management
Atezo + Bev in HCC
Featuring: Dr Michael Pishvaian
TAGs Trial
Featuring: Dr. Hendrik Tobias Arkenau
MODUL Study - Updates in Metastatic Colorectal Cancer
Featuring: Dr Scott Berry Dr Sharlene Gill Dr Marc Peeters
TRIBE 2 Study - Updates in Unresectable Metastatic Colorectal Cancer
TAGS Study - Updates in Metastatic Gastric Cancer
NIVO + IPI 1L - Updates in Metastatic Colorectal Cancer
InterAACT Study - Updates in Anal Cancer
Updates in Biliary Tract Cancer
KEYNOTE-181 study
Featuring: Dr. Daniel Renouf Dr. Scott Berry Dr. Sharlene Gill
The COMPASS Trial
Treatment BRAF V600E–mutated biliary tract cancer: a cohort of the ROAR basket trial
CCTG CO.26 trial
The COLOPEC Trial
NIVO + IPI 1L IN MSI-H/DMMR MCRC
Featuring: Dr. Heinz-Josef Lenz
Best of ASCO Vancouver 2018 - Colorectal GI Cancer
Best of ASCO Vancouver 2018 - Non-Colorectal GI Cancer
Featuring: Dr. Vincent Tam
Best of ASCO Toronto 2018 - Non-Colorectal GI Cancer
Featuring: Dr. Elena Elimova
Canadian Achievements in Cancer Research, PRODIGE 24
Featuring: Dr. Jim Biagi
Best of ASCO Toronto 2018 - Colorectal GI Cancer
Best of ASCO Montreal 2018 - GI Cancers (Non-Colorectal and Colorectal)
Featuring: Dr. Frederic Lemay
PRODIGE 24/PA.6 TRIAL - Updates in Pancreatic Cancer
Dr. Scott Berry Dr. Sharlene Gill Dr. Marc Peeters
PRODIGE 7 - Updates in Colorectal Cancer & Isolated Peritoneal Metastases
ECOG 7208 Study - Updates in Advanced Colorectal Cancer
ADORE Trial - Updates in Resected Rectal Cancer
REACH2 STUDY - Updates in Hepatocelluar Carcinoma
KEYNOTE-061 trial
Featuring: Dr. Charles Fuchs
PRODIGE 24/CCTG PA.6 Trial
Updates in Pancreatic Neuroendocrine Tumours
From Bench to Bedside with Bevacizumab Biosimilars
Best of GUGI 2018 - Pancreatic Cancer
Best of GUGI 2018 - Esophago-Gastro Cancer
Best of GUGI 2018 - Hepatobiliary Cancer
Best of GUGI 2018 - Colorectal Cancer
Featuring: Dr. Rachel Goodwin
Best of Oncology East 2017 - Colorectal GI Cancer
Featuring: Dr. Ronald Burkes
Best of Oncology East 2017 - Non-Colorectal GI Cancer
Debate: Should Patients with Resected Stage 3 Colon Cancer Receive 3 or 6 Months Oxaliplatin-Based Chemo? -3 months
Featuring: Dr. Jeff Myers
Debate: Should Patients with Resected Stage 3 Colon Cancer Receive 3 or 6 Months Oxaliplatin-Based Chemo? -6 months
Featuring: Dr. Robert El-Maraghi
Best of Oncology West 2018 - Colorectal GI Cancer
Best of Oncology West 2018 - Non-Colorectal GI Cancer
Featuring: Dr. Daniel Renouf
RAINFALL Trial: Chemotherapy With or Without Ramicirumab for Untreated Metastatic Gastric Cancer
Featuring: Dr. Scott Berry Dr. Daniel Renouf Dr. Sharlene Gill
FUGA-BT Trial: Gemcitabine plus S-1 vs Gemcitabine plus Cisplatin in Advanced Biliary Tract Cancer
Celestial Trial: Cabozantinib vs Placebo in Sorafenib Resistant Hepatocellular Carcinoma
Update on Checkmate 142
Video 1: Advanced in Colorectal Cancer
Video 2: Advanced in Non-Colorectal Cancer
JACOB Study: Pertuzumab in the 1st Line Treatment of HER2+ Metastatic Gastric Cancer
PRODIGE 18 Study
Featuring: Dr. Jaafar Bennouna
KEYNOTE-028 Study
Featuring: Dr. Janice Mehnert
VOLFI Trial of the AIO(AIO-KRK0109)
Featuring: Dr. Michael Geissler
German AIO KRK0110 (ML22011) Study
Featuring: Dr. Dominik Modest
Updates in Colorectal Cancer
Featuring: Dr. Scott Berry Dr. Hagen Kennecke Dr. Marc Peeters
Updates in Non-Colorectal Cancer
Case 1: Adjuvant Therapy
Featuring: Dr. Scott Berry Dr. Ramesh Ramanathan Dr. Robert El-Maraghi
Case 2: Metastatic Disease - First Line Options (Overview)
Case 3: Metastatic Disease - First Line Options (Older Patients and Patients with Poorer PS)
Case 4: Treating Metastatic Disease with Gemcitabine and Nab-Paclitaxel (Hyperbilirubinemia and A/E Management)
Alliance Trial: American Cancer Society Nutrition & Physical Activity Guidelines
Featuring: Dr. Erin Van Blarigan
SCOT Study: Final DFS Results
Featuring: Dr. Timothy Iveson
SIRveNIB Trial
Featuring: Dr. Pierce Chow
CALGB / SWOG 80405 (ALLIANCE) - Association of Mutations With OS
Featuring: Dr. Federico Innocenti
METIVHCC Trial
Featuring: Dr. Lorenza Rimassa
FLOT4-AIO Trial
CALGB / SWOG 80405 (Alliance) - Prognostic Value of Primary Tumor Location
Featuring: Alan P. Venook
IDEA Trial Summary
SWOG 21406 Trial 2
Featuring: Dr. Scott Kopetz
Breakfast Symposium
Gastric Cancer in 2016 - The important Role of Nutrition
Featuring: Dr. Christine Brezden-Masley Denise Gabrielson
Best of GUGI 2017 - Pancreatic Cancer
Featuring: Dr. Yooj Ko
Best of GUGI 2017 - Esophago-Gastro Cancer
Best of GUGI 2017 - Colon Cancer
Best of GUGI 2017 - Hepatobiliary Cancer
Featuring: Dr. Jennifer Knox
Best of ASCO Toronto 2017 - GI Colorectal Cancer
Best of ASCO Toronto 2017 - GI Non-Colorectal Cancer
Best of ASCO Montreal 2017 - GI Non-Colorectal Cancer
Featuring: Dr. Isabelle Gingras
Best of ASCO Vancouver 2017 - GI Colorectal Cancer
Featuring: Dr. Scot Dowden
Best of ASCO Vancouver 2017 - GI Non-Colorectal Cancer
Left vs Right-Sided Colorectal Tumours - Does Location of the Primary Impact Clinical Practice?
Featuring: Dr. Marc Peeters Dr. Rachel Goodwin, Chair
Best of Oncology West 2016 - GI Colorectal
Best of Oncology West 2016 - GI Non-Colorectal
Featuring: Dr. Christina Kim
Highlights from 2017 ASCO GI Symposium
Featuring: Dr. Scott Berry Dr. Daniel Renouf Dr. Winson Cheung Dr. Mustapha Tehfe
2016 Pancreatic Cancer Year in Review
Best of Oncology East 2016 - GI Colorectal Cancer
Best of Oncology East 2016 - GI Non-Colorectal Cancer
Innovative Approaches to the Management of Pancreatic Cancer
Featuring: Dr. Philip Philip
Treatment and Management Considerations in Advanced Pancreatic Cancer
Resectable Pancreatic Cancer and Beyond_The Role of Neoadjuvant and Adjuvant Therapies
Emerging Evidence in Localized Disease Management
The Future - Targeted Therapies for the Treatment of Pancreatic Adenocarcinoma
Approaches to Pancreatic and GI NETs Using the New Canadian Guidelines (English)
Featuring: Dr. Simron Singh Dr. Rachel Goodwin
Approaches to Pancreatic and GI NETs Using the New Canadian Guidelines (French)
Round Table Discussion: Colorectal Cancer Highlights from ESMO 2016
Featuring: Dr. Scott Berry Dr. Scot Dowden Dr. Hagen Kennecke
LUME-Colon 1 Study
GI Non-Colorectal Cancer Highlights
Featuring: Dr. Tim Asmis
CCTG/AGITG CO.23 Trial
Featuring: Dr. Derek Jonker
The FACS Randomized Clinical Trial
Featuring: Dr. John Primrose
Dabrafenib, Trametinib, and Panitumumab in BRAF V600E–Mutated mCRC
Featuring: Dr. Ryan Corcoran
NGS Identifies Distinct Molecular Signatures of HER2 Inhibition
Featuring: Dr. Yelena Janjigian
CheckMate-040 Study
Featuring: Dr. Ignacio Melero
GOLD Study
Featuring: Dr. Yung Bang
Webinar Archive: ASCO 2016 Updates
Key GI Cancer Trials
Best of ASCO Vancouver 2016 - GI Non-Colorectal Cancer
Best of ASCO Vancouver 2016 - GI Colorectal Cancer
Circulating Tumour DNA to Reshape the Design of Clinical Trials
Featuring: Dr. Jeanne Tie
Best of ASCO Toronto 2016 - GI Non-Colorectal Cancer
Best of ASCO Toronto 2016 - GI Colorectal Cancer
Best of ASCO Montreal 2016 - GI Non-Colorectal Cancer
Featuring: Dr. Thierry Alcindor
Best of ASCO Montreal 2016 - GI Colorectal Cancer
CALGB 80802 (NCIC HEC 1) & ESPAC-4 Updates
ESPAC-4 Trial
Featuring: Dr. John Neoptolemos
NETTER-1 Study
Featuring: Dr. Jonathan Strosberg
CREST Study
Featuring: Dr. James Hill
Analysis of CALGB/SWOG 80405 (Alliance)
Featuring: Dr. Alan Venook
Gastric Cancer in Ontario
Featuring: Dr. Natalie Coburn
Systemic Therapy for Metastatic Gastric Cancer
The Future of Stage IV Gastric Cancer Management
Featuring: Dr. Han-Kwang Yang
Best of GUGI 2016 - Pancreatic Cancers
Best of GUGI 2016 - Esophago-Gastro and Colorectal Cancer
Best of GUGI 2016 - Esophago-Gastro Cancer
Best of Oncology West 2017 - GI Non-Colorectal Cancers
Best of Oncology West 2017 - GI Colorectal Cancer
Dinner Symposium: The Management of Metastatic Gastric Cancer
Featuring: Dr. Sharlene Gill Dr. Emile Woo Dr. Howard Lim
EVOLVE: Module II: Chemotherapeutic Strategies Before & After Resection of Hepatic Metastases
EVOLVE: Module II: Curative-Intent Strategies in Metastatic Colorectal Cancer (mCRC)
EVOLVE: Module II: Conversion Strategies in Initially Unresectable mCRC Patients
EVOLVE: Module II: Biomarkers of Interest for Anti-EGFRs
EVOLVE: Module II: Targeted Therapies: Which Pathways are Involved in Their Mechanism of Action?
EVOLVE: Module II: The Role of Biomarkers in the Management of Metastatic Colorectal Cancer (mCRC)
EVOLVE: Module II: The Role of Targeted Agents in Initially Unresectable mCRC Patients
EVOLVE: Module I: Intermittent Chemotherapy
EVOLVE: Module I: Sequential Therapy
EVOLVE: Module I: What are the Options for Chemorefractory mCRC?
EVOLVE: Module I: What Strategies Help to Minimize the Toxicities of mCRC Treatment?
EVOLVE: Module I: Pallative First-Line Therapy in mCRC: What Role Can Biologics Play?
EVOLVE: Module I: Pallative-Intent Strategies in the Management of Metastatic Colorectal Cancer
EVOLVE: Module I:Pallative First-Line Therapy in mCRC: Comparing Biologics
EVOLVE: Module I: Pallative Second-Line Therapy in mCRC: Continuation of a Biologic After First-Line Progression
EVOLVE: Module I:Pallative First-Line Therapy in mCRC: Comparing BiologicsPallative Second-Line Therapy in mCRC: What Role Can Biologics Play?
Webinar Archive: Advanced Pancreatic Cancer: Current Clinical Options and Future Directions
Featuring: Dr. Malcolm Moore Dr. Hedy Kindler Dr. Scott Berry
Webinar Archive: Navigating Later Lines of Treatment for Advanced Colorectal Cancer
Featuring: Dr. Scott Berry Dr. Bruce Colwell Dr. Scot Dowden Dr. Sharlene Gill
Webinar Archive: A Case-Based Approach to Hepatocellular Carcinoma
Featuring: Dr. Ravi Ramjeesingh
BRAF Inhibitors in Colorectal Cancer - ENA 2014
Featuring: Dr. Philippe Bedard
